The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.
作者： S. M. DUNKLEY , K. YANG
DOI: 10.1111/J.1365-2516.2008.01927.X
关键词:
摘要:
sci-hub.se 参考文章(4)
J. Isbister, L. Phillips, S. Dunkley, G. Jankelowitz, J. McNeil, P. Cameron, Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register Internal Medicine Journal. ,vol. 38, pp. 156- 165 ,(2008) , 10.1111/J.1445-5994.2007.01472.X
T. Hayashi, I. Tanaka, M. Shima, K. Yoshida, K. Fukuda, Y. Sakurai, T. Matsumoto, J. C. Giddings, A. Yoshioka, Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia. ,vol. 10, pp. 397- 400 ,(2004) , 10.1111/J.1365-2516.2004.00924.X
M. SHIMA, T. MATSUMOTO, K. OGIWARA, New assays for monitoring haemophilia treatment. Haemophilia. ,vol. 14, pp. 83- 92 ,(2008) , 10.1111/J.1365-2516.2008.01737.X
J. Schneiderman, D. J. Nugent, G. Young, Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia. ,vol. 10, pp. 347- 351 ,(2004) , 10.1111/J.1365-2516.2004.00912.X